A Trial of Oxantel in Trichuriasis

Total Page:16

File Type:pdf, Size:1020Kb

A Trial of Oxantel in Trichuriasis Vol. 17, No. 4. SINGAPORE MEDICAL JOURNAL 219 December. 1976. A TRIAL OF OXANTEL IN TRICHURIASIS By Freda M. Paul and V. Zaman SYNOPSIS In this study we are reporting on the efficacy of Oxantel in eight Trichuriasis children admitted into the Paediatric Unit, Singapore General Hospital with gastrointestinal symptoms, protein caloric malnutrition and nutritional anaemia. Detailed case history is given of each of these cases to show their socio -economie background. Oxantel was administered in the form of a suspension given in a dose of 10 mgm per kilogram body weight twice a day usually for four days. Stool examination was conducted once before treatment and for consecutive days after treatment. This was followed whenever possible by one stool examination two weeks later and another after 3 months. The response to Oxantel was judged by its ability to relieve gastrointestinal symptoms such as diarrhoea, and decrease the ova count in the faeces. Oxantel was well tolerated by all patients and none of them showed any adverse reaction to the drug, which did not alter the morphology of the ova that was passed in the faeces. In one of the patients parasites re- appeared after a complete cure. This was certainly a case of re -infection, and indicates the importance of environmental sanitation in keeping the population free of intestinal helminthiasis. INTRODUCTION MATERIAL AND METHODS The most common intestinal helminth found in Oxantel was administered in the form of a Singapore and Malaysia is Trichuris trichiura suspension given in a dose of 10 mg/kg body weight (Desowitz et al, 1961; Lie, 1964). In a survey done in twice a day, usually for four days. Stool examina- the Singapore General Hospital 38% of the children tion was conducted once before treatment and for were found to be infected with Trichuris with the four consecutive days after treatment. This was highest prevalence rates amongst Malays, followed followed whenever possible by one stool examina- by Indians and the Chinese (Kan et al, 1971). tion 2 weeks later and another after 3 months. The technique of examination was that of an ordinary Chemotherapy of trichuriasis has been unsatis- direct smear using 2 mgm of faeces, according to until recently. Dithiazanine iodide which is factory Beaver's method (1950). an effective trichuricide is no longer used because of its serious side effects. Case 1 Recently, two anti-Trichuris drugs have been in- girl troduced; they are Mebendazole and Oxantel (Trans - Z.B.M.Y. was a 5-yéar old Malay and 1, 4, 5, 6 tetrahydro-2- (trans-3-hydroxystyryl)-1- admitted because of fever and reproductive cough of methyl pyrimidine (CP-14-445). In a previous study 8 days duration and was referred from a rural infant Mebendazole was shown by us to be an effective welfare clinic at Bedok. There was a past history of drug against this parasite (Paul and Zaman, 1975). diarrhoea for which the child had been treated In the present study we are reporting on the efficacy symptomatically at the infant welfare clinic. The eldest of Oxantel in 8 trichuriasis cases admitted into the child was the youngest of 10 children, the Paediatric Unit, Singapore General Hospital with being 20 years. The father earned only $100/- a gastro intestinal symptoms, protein -caloric month, as an odd job labourer, and he belonged to malnutrition and nutritional anaemia. Detailed case the lower income group. This child had been history is given of each of these cases to show their followed up regularly at the maternal and child socio-economic background. -, welfare clinic and although the initial weight at birth was normal, the weight gain was slow and she was at most times along the 25th percentile in weight. Physical examination revealed a height of 101 cm Department of Paediatrics, University of Singapore. and a weight of 13.4 kg, being 10th and 25th FREDA M. PAUL, percentile respectively, using Singapore standards. Associate Professor. She was malnourished and febrile with an injected Department of Parasitology, University of Singapore. throat and tonsils. There were also signs of V. ZAMAN, Ph.D., DSc, pneumonitis on the left side with diminished air Professor. entry and adventitious sounds. Blood examination 220 SINGAPORE MEDICAL JOURNAL showed a haemoglobin of 8.2 gm%a, a total white were giant myelocytes and megoloblasts as well. The cell count of 15,700 cm with polymorphs 67%, serum albumin was low being only 2.9 gm% while lymphocytes 17%, monocytes 3% and eosinophils the serum folic acid was also low being 2.0 ngm%. 13%. Platelet count was 690,090 cmm. Serum The culture of the stools did not reveal any protein showed a normal albumin globulin ratio 4.0 Salmonella, Mycelia or pathogenic E. coli but a gm% to 3.6 gm% respectively. Serum iron was 35 direct smear showed the presence of Ascaris and micrograms Wo and folic acid 25.0 ng/ml. The Trichuris ova. culture of the throat swab grew coliform organisms The child was put on a course of Ampicillin and with candida species. A radiograph of the chest Cloxacillin to clear the chest infection and she did the presence of consolidation of the left showed well. Examination of the stools revealed 60 Ascaris lung. Examination of the faeces showed the presence ova per 2 mgm and 7 Trichuris ova per 2 mgm of of Trichuris ova. The child was given a course of stool. The results of treatment with Oxantel were as Ampicillin and Cloxacillin for the chest infection follows:- and Oxantel for trichuriasis. The results of treatment with Oxantel were as follows:- Dosage of Date Ova Count Oxantel Dosage of Date Ova Count Oxantel 21.3.75 7 per 2 mgm Nil 22.3.75 7 per 2 mgm 10 mg/kg bd 6.3.75 248 per2mgm 10 mg/kgbd 23.3.75 4 per 2 mgm 10 mg/kg bd 189 2 10 7.3.75 per mgm mg/kg bd 26.3.75 0 per 2 mgm 10 mg/kg bd 8.3.75 68 per 2 mgm 10 mg/kg bd 27.3.75 0 per 2 mgm 10 mg/kg bd 9.3.75 Not done 10 mg/kg bd 10.3.75 21 per 2 mgm Nil was the roundworm 11.3.75 2per2mgm Nil In addition Piperazine given -for 13.3.75 0 per 2 mgm Nil infestation. Examination of the stool on 2.12.75 did not show The child was sent to a convalescent home at Chang' evidence of any ova. On her last check-up date on on 13.3.75 and she put on 2 kg in 31/2 months at the 30.3.75 she had grown by 7 cm and measured 107 home. The stools were examined at the end of cm, which was at the 10th percentile and weighed November 1975 and they showed no evidence of any 15.6 kg which was at the 10th percentile, using ova. In November 1975 the child was 17.5 kg (75th Singapore standards. The haemoglobin had risen to percentile) and measured 108 cm (50th percentile), 11.7 gm%. The Trichuris infestation in this child using Singapore standards. This showed that the was light and cleared within 2 days of treatment. child was cleared of trichuriasis infestation and had improved nutritionally. Case 3 P.E.T. was a 9 -year old Chinese child admitted Case 2 for an established rheumatic carditis with sub- cutaneous nodules. The history dated 15 days ago N.S.H. was an 8 -year old girl living in Jurong in when the child had fever with prominent nodules a rural area hut, admitted because of postmeasles over bony prominences, proximal interphalangeal bronchopneumonia. In addition, there was a history joints, and vertebral column, malleolus and fibula. of vomiting roundworms about 2-3 ascarids for the There was no past history of sore throat or past two days and a history of mild diarrhoea. The involuntary movements. In this particular case, child had a cough with nonproductive sputum and there was no past history of diarrhoea but because there was marked anorexia with loss of appetite. The the child came from a rural area of Singapore, a patient was the second in a family of 4 children and routine examination of the stools was done for belonged to the lower income group, the father Trichuris ova. Physical examination revealed a earning $300/- per month. height of 1.7 metres and a weight of 15 kg, both were Physical examination revealed a child who was below the 3rd percentile, using Singapore standards. severely wasted. She weighed 11.7 kg (3rd percentile) He had visible nodules over the occiput, vertebral and measured 99.6 cm (3rd percentile), using column, proximal interphalangeal joints, palmer Singapore standards. There was a postmeasles stain- surface, head of fibula and malleolus. The apex beat ing of the skin and the pharynx was congested. The was in the fourth left intercostal space three inches chest was full of bilateral crepitations. The liver was from the mid -sternal line, and there was a systolic 5 cm below the right costal margin. No abnormality thrill and bruit with a mid diastolic bruit due to could be detected in the other systems. Blood mitral incompetence and stenosis. The pulmonary examination showed a haemoglobin of 9.8 gm%, second sound was loud and fixed. The other systems with total white cell count of 11,200 cmm and a were essentially normal. Blood examination showed platelet count of 590,000 cmm. The serum iron was a haemoglobin of 10.4 gm%a, a total white cell count normal being 125 micrograms% but the bone - of 15,000 cmm with polymorphs 44%, lymphocytes marrow showed depletion of iron stores, and there 32%, monocytes 0% and eosinophils 24%.
Recommended publications
  • Chemotherapy of Gastrointestinal Helminths
    Chemotherapy of Gastrointestinal Helminths Contributors J. H. Arundel • J. H. Boersema • C. F. A. Bruyning • J. H. Cross A. Davis • A. De Muynck • P. G. Janssens • W. S. Kammerer IF. Michel • M.H. Mirck • M.D. Rickard F. Rochette M. M. H. Sewell • H. Vanden Bossche Editors H. Vanden Bossche • D.Thienpont • P.G. Janssens UNIVERSITATS- BlfiUOTHElC Springer-Verlag Berlin Heidelberg New York Tokyo Contents CHAPTER 1 Introduction. A. DAVIS A. Pathogenic Mechanisms in Man 1 B. Modes of Transmission 2 C. Clinical Sequelae of Infection 3 D. Epidemiological Considerations 3 E. Chemotherapy 4 F. Conclusion 5 References 5 CHAPTER 2 Epidemiology of Gastrointestinal Helminths in Human Populations C. F. A. BRUYNING A. Introduction 7 B. Epidemiological or "Mathematical" Models and Control 8 C. Nematodes 11 I. Angiostrongylus costaricensis 11 II. Anisakis marina 12 III. Ascaris lumbricoides 14 IV. Capillaria philippinensis 21 V. Enterobius vermicularis 23 VI. Gnathostoma spinigerum 25 VII. Hookworms: Ancylostoma duodenale and Necator americanus . 26 VIII. Oesophagostoma spp 32 IX. Strongyloides stercoralis 33 X. Ternidens deminutus 34 XI. Trichinella spiralis 35 XII. Trichostrongylus spp 38 XIII. Trichuris trichiura 39 D. Trematodes 41 I. Echinostoma spp 41 II. Fasciolopsis buski 42 III. Gastrodiscoides hominis 44 IV. Heterophyes heterophyes 44 V. Metagonimus yokogawai 46 X Contents E. Cestodes 47 I. Diphyllobothrium latum 47 II. Dipylidium caninum 50 III. Hymenolepis diminuta 51 IV. Hymenolepis nana 52 V. Taenia saginata 54 VI. Taenia solium 57 VII. Cysticercosis cellulosae 58 References 60 CHAPTER 3 Epidemiology and Control of Gastrointestinal Helminths in Domestic Animals J. F. MICHEL. With 20 Figures A. Introduction 67 I.
    [Show full text]
  • WO 2012/148799 Al 1 November 2012 (01.11.2012) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/148799 Al 1 November 2012 (01.11.2012) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 9/107 (2006.01) A61K 9/00 (2006.01) kind of national protection available): AE, AG, AL, AM, A 61 47/10 (2006.0V) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, PCT/US2012/034361 HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, (22) International Filing Date: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 20 April 2012 (20.04.2012) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, (26) Publication Language: English TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 61/480,259 28 April 201 1 (28.04.201 1) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, (71) Applicant (for all designated States except US): BOARD UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, OF REGENTS, THE UNIVERSITY OF TEXAS SYS¬ TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, TEM [US/US]; 201 West 7th St., Austin, TX 78701 (US).
    [Show full text]
  • Albendazole: a Review of Anthelmintic Efficacy and Safety in Humans
    S113 Albendazole: a review of anthelmintic efficacy and safety in humans J.HORTON* Therapeutics (Tropical Medicine), SmithKline Beecham International, Brentford, Middlesex, United Kingdom TW8 9BD This comprehensive review briefly describes the history and pharmacology of albendazole as an anthelminthic drug and presents detailed summaries of the efficacy and safety of albendazole’s use as an anthelminthic in humans. Cure rates and % egg reduction rates are presented from studies published through March 1998 both for the recommended single dose of 400 mg for hookworm (separately for Necator americanus and Ancylostoma duodenale when possible), Ascaris lumbricoides, Trichuris trichiura, and Enterobius vermicularis and, in separate tables, for doses other than a single dose of 400 mg. Overall cure rates are also presented separately for studies involving only children 2–15 years. Similar tables are also provided for the recommended dose of 400 mg per day for 3 days in Strongyloides stercoralis, Taenia spp. and Hymenolepis nana infections and separately for other dose regimens. The remarkable safety record involving more than several hundred million patient exposures over a 20 year period is also documented, both with data on adverse experiences occurring in clinical trials and with those in the published literature and\or spontaneously reported to the company. The incidence of side effects reported in the published literature is very low, with only gastrointestinal side effects occurring with an overall frequency of just "1%. Albendazole’s unique broad-spectrum activity is exemplified in the overall cure rates calculated from studies employing the recommended doses for hookworm (78% in 68 studies: 92% for A. duodenale in 23 studies and 75% for N.
    [Show full text]
  • Identification of Drug Candidates That Enhance Pyrazinamide Activity from a Clinical Drug Library
    bioRxiv preprint doi: https://doi.org/10.1101/113704; this version posted March 4, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Identification of drug candidates that enhance pyrazinamide activity from a clinical drug library Hongxia Niub, a, Chao Mac, Peng Cuid, Wanliang Shia, Shuo Zhanga, Jie Fenga, David Sullivana, Bingdong Zhu b, Wenhong Zhangd, Ying Zhanga,d* a Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA b Lanzhou Center for Tuberculosis Research and Institute of Pathogenic Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China c College of Biological Sciences and Technology, Beijing Forestry University, Beijing 100083, China d Key Laboratory of Medical Molecular Virology, Department of Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China *Correspondence: Ying Zhang, E-Mail: [email protected] Tuberculosis (TB) remains a leading cause of morbidity and mortality globally despite the availability of the TB therapy. 1 The current TB therapy is lengthy and suboptimal, requiring a treatment time of at least 6 months for drug susceptible TB and 9-12 months (shorter Bangladesh regimen) or 18-24 months (regular regimen) for multi-drug-resistant tuberculosis (MDR-TB). 1 The lengthy therapy makes patient compliance difficult, which frequently leads to emergence of drug-resistant strains. The requirement for the prolonged treatment is thought to be due to dormant persister bacteria which are not effectively killed by the current TB drugs, except rifampin and pyrazinamide (PZA) which have higher activity against persisters.
    [Show full text]
  • Comparative Genomics of the Major Parasitic Worms
    Comparative genomics of the major parasitic worms International Helminth Genomes Consortium Supplementary Information Introduction ............................................................................................................................... 4 Contributions from Consortium members ..................................................................................... 5 Methods .................................................................................................................................... 6 1 Sample collection and preparation ................................................................................................................. 6 2.1 Data production, Wellcome Trust Sanger Institute (WTSI) ........................................................................ 12 DNA template preparation and sequencing................................................................................................. 12 Genome assembly ........................................................................................................................................ 13 Assembly QC ................................................................................................................................................. 14 Gene prediction ............................................................................................................................................ 15 Contamination screening ............................................................................................................................
    [Show full text]
  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
    MTC eHealth DSI [eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01
    [Show full text]
  • Anthelmintics Are Drugs Used to Treat Parasitic Infections Due to Worms
    “ANTHEMINTICS" Presented By Mr.Ghule A.V. Assistant Professor, MES’S,College Of Pharmacy,Sonai. INTRODUCTION Helminth means worms. Helminthiasis is an infections caused by parasitic worms. Anthelmintics are drugs used to treat parasitic infections due to worms. Anthelmintics act through two mechanism . Vermicide (kill) used to kill parasitic intestinal worms. Vermifuge (expel) used to destroy or expel worms in the intestine. Helminths are 3 types Nematodes (round worms) - ascarids (Ascaris), filarias, hookworms, pinworms (Enterobius), and whipworms (Trichuris trichiura) Cestodes (tape worms) - multiple species of flat worms, Taenia saginatum, Taenia solium(cysticercosis, hydatid(echinococcus), Trematodes (flukes) – liver flukes, lung flukes, schistosoma BASED ON CHEMICAL STRUCTURES Benzimidazoles : Albendazole , Mebendazole ,Flubendazole, Cyclobendazole Thiabendazole, Fenbendazole, Oxibendazole, Parbendazole Quinolines and isoquinolines [Heterocyclics]: Oxamniquine, Praziquantel Piperazine derivatives: Piperazine citrate, Diethyl carbamazine Vinyl pyrimidines: Pyrantel pamoate, Oxantel Amides : Niclosamide Natural products: Ivermectin Organo phosphorus: Metrifonate Imidazothiazoles: Levamisole Nitro derivatives: Niridazol BENZIMIDAZOLES Benzimidazole is a heterocyclic aromatic organic compound. This bicyclic compound consists of the fusion of benzene and imidazole. Many anthelmintic drugs(albendazole, mebendazole, etc.) belong to the benzimidazole class of compounds. ALBENDAZOLE It selectively bind to nematode ß-tubulin
    [Show full text]
  • Summary of Product Characteristics
    Vetoquinol/DOLPAC Small dogs/European Renewal June 2011 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Austria Belgium Cyprus Malta Czech Republic Netherlands Greece Dolpac small dogs tablets Portugal Slovakia Hungary Slovenia Germany Finland France Luxembourg Dolpac 2 comprimé UK-Ireland-Italy Dolpac Tablets for Small Dogs Spain Dolpac small dogs tablets for 1-6 Poland kg Denmark Dolpac vet small dogs tablets Sweden 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Active substances Oxantel 40.06 mg (equivalent to 111.8 mg of oxantel embonate) Pyrantel 9.99 mg (equivalent to 28.8 mg of pyrantel embonate) Praziquantel 10.00 mg Excipient to one 190 mg divisible tablet Excipients For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet Pale yellow to yellow, elongated, divisible oblong tablet with breaking line; 4. CLINICAL PARTICULARS 4.1 Target species Dogs 4.2 Indications for use, specifying the target species For curative treatment of dogs harbouring mixed parasitic infestations with the following adult stages of nematode and cestode species: Nematodes: Toxocara canis Toxascaris leonina Ancylostoma caninum 1/10 Vetoquinol/DOLPAC Small dogs/European Renewal June 2011 Uncinaria stenocephala Trichuris vulpis Cestodes: Dipylidium caninum Taenia spp Echinococcus multilocularis Echinococcus granulosus 4.3 Contraindications See section 4.8. 4.4 Special warnings for each target species Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class. Fleas serve as intermediate hosts for one of the common tapeworms – Dipylidium caninum. Tapeworm infestation may reoccur unless control of intermediate hosts (fleas) is undertaken.
    [Show full text]
  • Addendum A: Antiparasitic Drugs Used for Animals
    Addendum A: Antiparasitic Drugs Used for Animals Each product can only be used according to dosages and descriptions given on the leaflet within each package. Table A.1 Selection of drugs against protozoan diseases of dogs and cats (these compounds are not approved in all countries but are often available by import) Dosage (mg/kg Parasites Active compound body weight) Application Isospora species Toltrazuril D: 10.00 1Â per day for 4–5 d; p.o. Toxoplasma gondii Clindamycin D: 12.5 Every 12 h for 2–4 (acute infection) C: 12.5–25 weeks; o. Every 12 h for 2–4 weeks; o. Neospora Clindamycin D: 12.5 2Â per d for 4–8 sp. (systemic + Sulfadiazine/ weeks; o. infection) Trimethoprim Giardia species Fenbendazol D/C: 50.0 1Â per day for 3–5 days; o. Babesia species Imidocarb D: 3–6 Possibly repeat after 12–24 h; s.c. Leishmania species Allopurinol D: 20.0 1Â per day for months up to years; o. Hepatozoon species Imidocarb (I) D: 5.0 (I) + 5.0 (I) 2Â in intervals of + Doxycycline (D) (D) 2 weeks; s.c. plus (D) 2Â per day on 7 days; o. C cat, D dog, d day, kg kilogram, mg milligram, o. orally, s.c. subcutaneously Table A.2 Selection of drugs against nematodes of dogs and cats (unfortunately not effective against a broad spectrum of parasites) Active compounds Trade names Dosage (mg/kg body weight) Application ® Fenbendazole Panacur D: 50.0 for 3 d o. C: 50.0 for 3 d Flubendazole Flubenol® D: 22.0 for 3 d o.
    [Show full text]
  • Selection of New Chemicals to Be Used in Conditioned Aversion for Non-Lethal Predation Control 2
    1 Selection of new chemicals to be used in conditioned aversion for non-lethal predation control 2 3 Jorge Tobajasa,*, Pilar Gómez-Ramíreza,b,c, Pedro María-Mojicab, Isabel Navasb,c, 4 Antonio Juan García-Fernándezb,c, Pablo Ferrerasa, Rafael Mateoa 5 6 aInstituto de Investigación en Recursos Cinegéticos (IREC), CSIC-UCLM-JCCM, Ronda de 7 Toledo No. 12, 13071, Ciudad Real, Spain. 8 bToxicology Area, Department of Health Sciences, Faculty of Veterinary, University of 9 Murcia, Campus de Espinardo, 30100 Murcia, Spain. 10 cToxicology and Risk Assessment Group, Biomedical Research Institute of Murcia (IMIB- 11 Arrixaca), University of Murcia, Campus de Espinardo, 30100 Murcia, Spain. 12 13 *Corresponding author 14 E-mail address: [email protected] (J. Tobajas) 15 1 16 Abstract 17 The use of conditioned food aversion (CFA) can reduce the predation conflict and 18 therefore the incidence of illegal poisoning, which is one of the most important 19 conservation threats for predators and scavengers around the world. CFA is a robust 20 learning paradigm that occurs when animals associate a food with a discomfort 21 induced by a chemical, thereby avoiding that food in subsequent encounters. We 22 reviewed the potential of 167 chemical compounds to be used in CFA, considering 23 effects, margin of safety, accessibility, and detectability. After the review, 15 24 compounds fulfilled the required characteristics, but only five were finally selected to 25 be tested in CFA assays with dogs. Of the tested compounds, thiabendazole, thiram 26 and levamisole caused target food rejection by dogs and reduced the time spent eating 27 during post-conditioning.
    [Show full text]
  • Parasitic Infections (1 of 14)
    Parasitic Infections (1 of 14) 1 Patient presents w/ signs & symptoms suggestive of GI parasitic infection 2 DIAGNOSIS No ALTERNATIVE Is a GI parasitic infection DIAGNOSIS confi rmed? Yes Protozoal or helminthic infection? Protozoal Infection Helminthic Infection A Rehydration & nutrition B Prevention PHARMACOLOGICAL PHARMACOLOGICAL THERAPY FOR THERAPY FOR PROTOZOAL HELMINTHIC INFECTIONS INFECTIONS ©See page 3 MIMSSee page 3 B1 © MIMS 2019 Parasitic Infections (2 of 14) 1 SIGNS & SYMPTOMS OF GI PARASITIC INFECTIONS GI Symptoms • Abdominal pain, diarrhea, dysentery, fl atulence, malabsorption, symptoms of biliary obstruction Nonspecifi c Symptoms • Fever, malaise, fatigue, anorexia, sweating, wt loss, edema & pruritus • Some patients may be asymptomatic PARASITIC INFECTIONS PARASITIC 2 DIAGNOSIS Clinical History • Attempt to elicit a history of possible exposure, especially for helminthic infections, eg eating undercooked meat, source of drinking water, swimming in fresh water where certain parasites may be endemic • Knowledge of the geographic distribution of parasites is helpful in the diagnosis of patients Host Susceptibility Factors in GI Parasitic Infections • Nutritional status • Intercurrent disease • Pregnancy • Immunosuppressive drugs • Presence of a malignancy Physical Exam Findings • Pallor • Hepatomegaly • Ascites • Ileus • Rectal prolapse Lab Tests Microscopic Exam of Stools • Fundamental to the diagnosis of all GI infections - A minimum of 3 stool specimens, examined by trained personnel using a concentration & a permanent stain
    [Show full text]
  • Oxantel 5 Oxantel 5
    Oxantel® 5 Oxantel® 5 Tabletas Palatables Palatable Tablets Antiparasitario interno Internal Antiparasitic agrovetmarket s.a. agrovetmarket s.a. FORMULACIÓN FORMULATION Cada tableta contiene: Each tablet contains: Oxibendazole……………65.00 mg Oxibendazole……………65.00 mg Praziquantel……………. 37.50 mg Praziquantel……………. 37.50 mg Excipientes c.s.p…........ 1 Tableta Excipients q.s.ad…......... 1 Tablet GENERALIDADES GENERAL ® La combinación antiparasitaria de estos componentes en Oxantel 5 actúa The antiparasitic combination of these components in Oxantel® 5 effectively acts efectivamente contra todos los cestodes (taenias) y nematodos (gusanos against all cestodes (taenias) and nematode (round worms) in dogs and cats. redondos) en perros y gatos. Praziquantel is the most effective antiparasitic against immature and adult forms El praziquantel es el antiparasitario de mayor efectividad contra formas, of all kind of taenias (cestoda). Its spectrum includes total effectiveness against inmaduras y adultas, de todo tipo de Taenias (Cestodes). Su espectro incluye Echinococcus granulosus, Taenia ovis, T. hydatigena, T. pisiformis, Dipylidium efectividad total contra: Echinococcus granulosus, Taenia ovis, T. Hydatigena, T. caninum, among others. Meanwhile oxibendazole is a broad spectrum pisiformis, Dipylidium caninum, entre otros. Por su parte el oxibendazole es un anthelmintic and works against many nematodes: Toxocara canis, T. leonina, antihelmíntico de amplio espectro y actúa contra muchos nematodos: Toxocara Ancylostoma caninum, hookworm and even Trichuris vulpis. canis, T. Leonina, Ancylostoma caninum, Uncinaria stenocephala e inclusive Trichuris vulpis. INDICATIONS Oxantel® 5 is an internal antiparasitic indicated for dogs and cats for the INDICACIONES treatment of infestations of cestodes and nematodes. Oxantel® 5 es un antiparasitario interno indicado para perros y gatos para el tratamiento de infestaciones por cestodes y nematodos.
    [Show full text]